The SCHMID Group N.V. (SHMD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer listed on The Nasdaq Capital Market. SCHMID files reports such as Form 20‑F for its annual financial statements and Form 6‑K for interim updates and material information, in line with its status as a Netherlands-incorporated group with headquarters in Freudenstadt, Germany.
In its recent Form 6‑K submissions, SCHMID has furnished press releases on topics including unaudited half-year financial results, updated guidance, financing transactions and Nasdaq listing matters. These filings describe revenue trends, operating results and non‑IFRS measures such as adjusted EBITDA, along with commentary on order intake, market conditions and the status of the company’s audit and reporting timetable. They also outline key financing steps, such as share issuances to offset financial liabilities, a waiver of certain shareholder loans and a secured two‑tranche term loan facility with an equity conversion feature.
Other 6‑K reports detail the company’s receipt of a Nasdaq staff determination letter regarding non-compliance with a filing requirement and the potential delisting of its ordinary shares and warrants, as well as SCHMID’s intention to appeal and request a stay of any suspension. These documents help investors understand the regulatory context around SHMD’s listing and the company’s plans to complete and file its Annual Report on Form 20‑F for the year ended December 31, 2024.
On Stock Titan, SCHMID’s SEC filings are updated as new documents are posted to the EDGAR system. AI-powered summaries highlight the main points of lengthy filings, helping readers quickly identify information on financial performance, capital structure changes, listing status and other material developments without reading every page. Users can review historical 20‑F annual reports, 6‑K current reports and related exhibits to follow how SCHMID’s business, financing arrangements and regulatory status evolve over time.
SCHMID Group N.V. (SHMD) is registering the resale of 4,958,481 ordinary shares issued on May 23, 2026, to offset €30.75 million of liabilities. The selling securityholders may sell for their own accounts; SCHMID will receive no proceeds from resales.
For the six months ended June 30, 2026, revenue was €46.0 million, compared with €16.9 million a year earlier. Adjusted EBITDA was €(0.6) million, compared with €(11.6) million, while net loss increased to €47.8 million from €10.2 million, primarily due to non-cash accounting effects related to the XJ Harbour liability conversion and, to a lesser extent, warrant fair-value movements. Operating cash use was €29.3 million, and cash and cash equivalents were €2.3 million as of June 30, 2026.
SCHMID confirmed 2026 revenue guidance of more than €100 million and order-intake guidance of €125–150 million, expecting the upper half of that range, but lowered Adjusted EBITDA margin guidance to 6% to 9% from more than 12%. A planned China campus is expected to nearly double effective capacity, with approximately €11 million of investment; construction is expected after final land transfer, permitting and a final binding agreement, and operations are expected in the fourth quarter of 2027.
SCHMID Group N.V.’s amended prospectus covers resale of up to 10,362,693 ordinary shares issuable upon conversion of its $20 million 2029 Convertible Notes; no additional securities are registered by this amendment. Selling securityholders offer the shares for their own accounts, and SCHMID receives no resale proceeds. The notes’ conversion price has a $1.93 floor and a $10.50 maximum per share.
For the six months ended June 30, 2026, revenue was €46.0 million versus €16.9 million in first-half 2025; gross profit was €9.8 million versus a €1.6 million loss. Adjusted EBITDA loss was €0.6 million versus €11.6 million, while net loss widened to €47.8 million from €10.2 million. Operating cash used was €29.3 million, and cash and cash equivalents were €2.3 million as of June 30.
Management confirmed 2026 revenue guidance of more than €100 million and maintained order-intake guidance of €125–150 million, expecting the upper half; it lowered adjusted EBITDA margin guidance to 6% to 9% from more than 12%. Cash and cash equivalents were approximately €14.3 million as of July 31, 2026, and approximately $21 million remained available at the company’s discretion under the SEPA. NASDAQ confirmed compliance on February 19, 2026, with panel monitoring through February 19, 2027.
SCHMID Group N.V. (SHMD) is updating its Form F-1 shelf registration, which covers issuance of up to 46,611,659 Ordinary Shares mainly upon conversion of convertible notes and loans, and exercise of public, private and 2026 warrants, 2025 options, and management incentive awards. The same registration also supports the resale by selling securityholders of up to 89,341,198 Ordinary Shares and 9,750,000 warrants, from business-combination shares, financing instruments and incentive arrangements. Ordinary Shares outstanding are 66,637,954 (including 5,000,000 earn-out shares that may be cancelled); if all registered instruments and other referenced facilities are fully exercised or converted and other registered shares are issued, up to 131,052,850 Ordinary Shares would be outstanding. SCHMID describes recent recapitalization steps (convertible notes, a standby equity facility and debt-for-equity set‑offs), a planned new manufacturing campus in China, and interim 2026 results showing higher revenue but continued losses, along with reduced full‑year Adjusted EBITDA guidance and cost‑saving programs.
SCHMID Group N.V. (SHMD) is filing a post-effective amendment to its Form F-1 to update a resale registration for up to 5,000,000 ordinary shares held by Yorkville under a Standby Equity Purchase Agreement (SEPA) and to incorporate recent financings, business developments and unaudited results for the six months ended June 30, 2026. The SEPA provides up to $30 million of discretionary equity financing; as of this amendment, SCHMID has issued 1,490,000 shares to Yorkville for roughly $9.0 million, leaving 3,510,000 shares registered for potential future issuance and about $21 million available. SCHMID reports strong top-line growth but continued losses, heavy non-cash charges, negative operating cash flow and negative equity, while maintaining 2026 revenue guidance above €100 million and cutting its Adjusted EBITDA margin target to 6–9%. The company details multiple debt and equity transactions, including $30 million 2028 and $20 million 2029 convertible notes, debt-for-equity swaps with major creditors and shareholders, and plans for a new China manufacturing campus to expand capacity.
SCHMID Group N.V. (SHMD) has filed a post‑effective amendment to its Form F‑1 registration statement to update financials and recent developments while continuing to register the resale of 4,958,481 Ordinary Shares held by existing shareholders. These shares were issued on May 23, 2026 to Anette, Christian and Christine Schmid and Schmid Grundstücke GmbH & Co KG in private placements that offset €30.75 million of liabilities.
The company will not receive any proceeds from these resales; all sales, if any, will be for the selling securityholders’ own accounts. The amendment incorporates unaudited results for the six months ended June 30, 2026, where revenue rose to €46.0 million but net loss was €47.8 million, and updates 2026 guidance, capital structure moves (convertible notes, term loan and SEPA equity line) and other recent developments. As of the prospectus date, controlling shareholders held just over half of the 61,637,954 issued and outstanding Ordinary Shares, with an additional 5,000,000 earn‑out shares issued but unvested and subject to cancellation.
SCHMID Group N.V. (SHMD) has filed a post-effective amendment to its Form F-1 registering the resale by selling securityholders of up to 10,362,693 Ordinary Shares issuable upon conversion of its $20 million 5.000% 2029 Convertible Notes. The amendment updates the prospectus with unaudited interim financial statements as of June 30, 2026, first-half 2026 results, revised full-year 2026 guidance and recent financing and operational developments, including prior 2028 convertible notes, the Yorkville standby equity facility and a planned new manufacturing campus in China. SCHMID remains an emerging growth company, a foreign private issuer and a controlled company under Nasdaq rules; Ordinary Shares outstanding were 66,637,954 including 5,000,000 unvested earn-out shares, and would be 77,000,647 if all shares registered here are issued.
SCHMID Group N.V. (SHMD) director Ralf Speth reported multiple acquisitions of Ordinary Shares. On August 31, 2026 he purchased 35,000 shares in open-market or private transactions at $3.248 per share, and on September 2, 2026 he purchased 33,000 shares at $3.05 per share. Earlier, on May 23, 2026 he received a grant or award of 16,311 shares at a reported value of $5.8647 per share. No Rule 10b5-1 plan is reported, and post-transaction share holdings are not stated in this filing.
SCHMID Group N.V. (SHMD) director and ten percent owner Anette Schmid reported an indirect open-market purchase of 69,000 Ordinary Shares on 2026-08-30 at $3.1623 per share, through Schmid Aequitas GmbH & Co. KG. Following this transaction, she indirectly holds 13,749,589 Ordinary Shares and, as noted in a footnote, also directly holds 13,111 Ordinary Shares.
SCHMID Group N.V. (SHMD) reported that its CFO, Arthur Josef Hermann Schuetz, purchased 15,200 Ordinary Shares on August 28, 2006 in a transaction coded as a purchase in an open market or private transaction at a price of $3.23 per share. Following this buy, his directly held stake totaled 29,512 Ordinary Shares.
SCHMID Group N.V. (SHMD) filed a prospectus supplement for a resale registration of up to 10,362,693 Ordinary Shares, all issuable upon conversion of its 2029 Convertible Notes, by existing selling securityholders. SCHMID will not sell shares itself under this supplement. The Ordinary Shares trade on Nasdaq under ticker SHMD, with a last reported price of $4.91 on August 21, 2026.
The supplement also includes SCHMID’s unaudited H1 2026 results and updated 2026 outlook. Revenue for the first half of 2026 rose to €46.0 million from €16.9 million in H1 2025, driven by Technical Equipment & Processes revenue of €39.4 million. Despite this, net loss widened to €47.8 million, mainly due to a €38.8 million negative financial result and higher expenses. Adjusted EBITDA was €-0.6 million.
Order intake reached €96.6 million year-to-date as of August 21, 2026, with order backlog at €95.0 million. SCHMID reaffirmed 2026 revenue guidance of more than €100 million and order intake guidance of €125–150 million but reduced its 2026 Adjusted EBITDA margin guidance to 6–9% from previously more than 12%. Liquidity improved following issuance of $20.0 million 2029 Convertible Notes, bringing cash to about €14.3 million as of July 31, 2026, and management expects available liquidity and operating cash flows to fund operations for at least the next twelve months.